Long Term Investors Who Hold Shares of Twist Bioscience Corporation (NASDAQ: TWST) Since 2019 Should Contact the Shareholders Foundation
SAN DIEGO, CA / ACCESSWIRE / March 14, 2023 / The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Twist Bioscience Corporation (NASDAQ:TWST).
Investors who purchased shares of Twist Bioscience Corporation (NASDAQ:TWST) prior to December 2019 and continue to hold any of those NASDAQ: TWST shares also have certain options. Those NASDAQ: TWST investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On December 12, 2022, a lawsuit was filed on behalf of certain investors in NASDAQ: TWST shares over alleged violations of Securities Laws by Twist Bioscience Corporation. The plaintiff alleges that the defendants repeatedly assured investors that the company possessed innovative proprietary technology relating to its synthetic DNA products that positioned Twist for significant future growth, that the Defendants claimed that Twist had already achieved substantial growth between December 13, 2019, and November 14, 2022, growing from a customer base of approximately 1,300 diagnostic companies, hospitals, research institutions, and others at the end of fiscal year 2019, to approximately 2,900 customers at the end of fiscal year 2021, and that as alleged in the report by Scorpion Capital, Defendants overstated the commercial viability of Twist's synthetic DNA manufacturing technology while engaging in accounting fraud and using unsustainable pricing to inflate the company's true financial condition and prospects, and that as a result of Defendants' wrongful acts and omissions, and the significant decline in the market value of Twist's common stock, investors between December 13, 2019, and November 14, 2022 have suffered significant damages.
Those who purchased Twist Bioscience Corporation (NASDAQ: TWST) shares should contact the Shareholders Foundation, Inc.
CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.
SOURCE: Shareholders Foundation, Inc.
View source version on accesswire.com:
https://www.accesswire.com/743603/Long-Term-Investors-Who-Hold-Shares-of-Twist-Bioscience-Corporation-NASDAQ-TWST-Since-2019-Should-Contact-the-Shareholders-Foundation
